Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Rui Zhao

Matched on ORCID iD 0000-0002-3069-7940; OpenAlex author ID A5100674308. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. Co-author DOI 10.3748/wjg.v31.i26.109500↗
  2. RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial-mesenchymal transition. Co-author DOI 10.1186/s40170-024-00362-2↗
  3. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study. Co-author DOI 10.1002/cam4.5296↗
  4. Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/20552076231179007↗
  5. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s11596-022-2535-2↗
  6. Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma. First author DOI 10.3389/fonc.2021.744667↗
  7. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00261-020-02506-6↗
  8. Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma. First author DOI 10.3389/fonc.2020.01618↗
  9. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. Co-author DOI 10.1371/journal.pone.0211566↗
  10. Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images. Co-author DOI 10.3389/fonc.2019.01171↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuai Ren · 8 shared papers, 2019–2023 · strength 1.10
  2. Zhongqiu Wang · 7 shared papers, 2019–2023 · strength 0.99
  3. Yingying Cao · 5 shared papers, 2020–2025 · strength 0.92
  4. Kai Guo · 5 shared papers, 2020–2023 · strength 0.71
  5. Rong Chen · 4 shared papers, 2019–2022 · strength 0.51
  6. Zipeng Lu · 3 shared papers, 2021–2023 · strength 0.48
  7. Shuai Ren · 1 shared paper, 2025 · strength 0.33
  8. Xiao Chen · 3 shared papers, 2019–2021 · strength 0.33
  9. Jianwei Xu · 1 shared paper, 2024 · strength 0.23
  10. Han Liu · 1 shared paper, 2024 · strength 0.23
  11. Feng Li · 1 shared paper, 2024 · strength 0.23
  12. Lei Wang · 1 shared paper, 2024 · strength 0.23
  13. Wenli Qiu · 2 shared papers, 2019–2020 · strength 0.21
  14. Yuan Li · 1 shared paper, 2023 · strength 0.18
  15. Jian He · 1 shared paper, 2023 · strength 0.17
  16. Kai Zhang · 1 shared paper, 2023 · strength 0.17
  17. Donghui Li · 1 shared paper, 2023 · strength 0.17
  18. Tao Li · 1 shared paper, 2021 · strength 0.13
  19. Zhonglan Wang · 1 shared paper, 2019 · strength 0.11
  20. Zhongqiu Wang · 1 shared paper, 2019 · strength 0.11
  21. Jingjing Zhang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.